Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenyang Tongluo Recipe is a Traditional Chinese Medicine (TCM) herbal formula developed by the Yunnan Hospital of Traditional Chinese Medicine for the treatment of refractory rheumatoid arthritis (RRA), specifically the cold syndrome (Fenghan Shibi) subtype. The formula is designed to warm yang and unblock collaterals to relieve joint pain and stiffness. Clinical research focuses on its potential to overcome multi-drug resistance in RRA patients by modulating the expression of ATP-binding cassette (ABC) transporters, specifically P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP), which are associated with reduced efficacy of conventional disease-modifying antirheumatic drugs (DMARDs).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wenyang Tongluo Recipe.